Author

P. V. Shelyakin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:machine learning (classical)· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

D. M. Chudakov· 2 shared A. A. Kesnikov· 1 shared A. I. Nekrasova· 1 shared A. Pivnyuk· 1 shared A. R. Zaretsky· 1 shared A. Y. Komkov· 1 shared D. K. Lukyanov· 1 shared D. Korneeva· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. M. Chudakov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Robust detection of SARS-CoV-2 exposure in population using T-cell repertoire profiling

E. K. Vlasova, A. I. Nekrasova, A. Y. Komkov, M. Izraelson, E. A. Snigir, S. I. Mitrofanov, V. S. Yudin, V. V. Makarov, A. A. Kesnikov, D. Korneeva, A. Pivnyuk, P. V. Shelyakin, I. Z. Mamedov, D. V. Rebrikov, D. M. Chudakov, , M. A. Shugay

The paper develops a classifier for detecting SARS-CoV-2 exposure using T-cell repertoire profiling and machine learning, achieving high accuracy across different protocols.

bioRxiv · Nov 8, 2023 · PreprintImmunology

Accounting for B cell behaviour and sampling bias yields a superior predictor of anti-PD-L1 response in bladder cancer

I. A. Dyugay, D. K. Lukyanov, M. A. Turchaninova, A. R. Zaretsky, O. A. Khalmurzaev, V. B. Matveev, M. M. Shugay, P. V. Shelyakin, D. M. Chudakov

The paper develops a RNA-Seq-based predictor of anti-PD-L1 response in bladder cancer by integrating B, NK, and T cell components and accounting for sampling bias.

bioRxiv · Mar 4, 2021 · PreprintImmunology